KK

Kumra Karan

Director Director DIN 03016393
DIN 03016393 First appointment Mar 2010 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Mar 2010
Shareholding value β€’β€’β€’β€’ Premium profile

About Kumra Karan

Data last updated:

Kumra Karan was a Director at Askmed Life Sciences Private Limited (2010–2020) and Director at Petra Life Sciences Private Limited (from 2010). The companies operate in Healthcare.

DIN 03016393
Primary Designation Director
Industry Healthcare
First Appointment 24 Mar 2010
Oldest Company Age 16 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Askmed Life Sciences Private Limited U24100MH2009PTC193729
Director24 Mar 20102009₹6.7 Lakh (FY 2024)Active
Petra Life Sciences Private Limited U24100MH2010PTC202026
Director13 Apr 20102010Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Petra Life Sciences Private Limited
Askmed Life Sciences Private Limited
Premium access

Shareholding and investment profile for Kumra Karan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kumra Karan

Kumra Karan was first appointed on 24 Mar 2010 as Director at Askmed Life Sciences Private Limited.

Kumra Karan held 2 earlier board appointments: Askmed Life Sciences Private Limited (Director, 24 Mar 2010 to 27 Jan 2020); Petra Life Sciences Private Limited (Director, from 13 Apr 2010).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available